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Previous studies showed that the HIV-1 envelope (Env) protein was not incorporated into vesicular stomatitis virus (VSV)
virions unless its cytoplasmic tail was replaced with that of the VSV glycoprotein (G). To determine whether the G tail provided
a positive incorporation signal for Env, or if sequences in the Env tail prevented incorporation, we generated mutants of Env
with its 150-amino-acid tail shortened to 29, 10, or 3 amino acids (Envtr mutants). Cells infected with VSV recombinants
expressing these proteins or an Env-G tail hybrid showed similar amounts of Env protein at the surface. The Env-G tail hybrid
or the Envtr3 mutant were incorporated at the highest levels into budding VSV virions. In contrast, the Envtr29 or Envtr10
mutants were incorporated poorly. These results defined a signal preventing incorporation within the 10 membrane-proximal
amino acids of the Env tail. Confocal microscopy revealed that this signal functioned by causing localization of human
immunodeficiency virus type 1 Env to plasma membrane domains distinct from the VSV budding sites, where VSV proteins
were concentrated. © 1998 Academic Press
INTRODUCTION
Enveloped viruses that bud from the cell surface can
preferentially incorporate their own envelope glycopro-
teins. Interactions between the cytoplasmic domains of
the viral glycoproteins and internal viral components are
generally thought to be responsible for this preferential
incorporation (Simons and Garoff, 1980). For some vi-
ruses, such interactions are well documented. For exam-
ple, initial studies suggested that alphavirus spike gly-
coproteins interact directly with nucleocapsid cores be-
cause such interactions could be disrupted by mutations
in the cytoplasmic domains of these glycoproteins (Suo-
malainen et al., 1992; Zhao et al., 1994). More recent work
has shown direct interactions between hydrophobic
amino acids in the capsid protein and those in the
cytoplasmic tail of the spike glycoprotein E2 (Lee et al.,
1996; Owen and Kuhn, 1997; Skoging et al., 1996). In
addition, there is substantial evidence that during the
assembly of human immunodeficiency virus type 1 (HIV-
1), the envelope protein (Env) tail interacts with the matrix
protein, one of the internal Gag proteins. Mutations in
either the matrix protein or the Env cytoplasmic tail can
lead to decreased incorporation of HIV-1 Env into bud-
ding virions (Cosson, 1996; Dorfman et al., 1994; Dubay
et al., 1992; Freed and Martin, 1995, 1996; Yu et al., 1992,
1993).
Work with vesicular stomatitis virus (VSV), the proto-
type of the rhabdovirus family, suggested that the cyto-
plasmic tail of its glycoprotein, G, was important in virion
assembly. Early studies with a VSV G mutant not ex-
pressed on the cell surface showed a low level of pro-
duction of noninfectious VSV particles lacking G (Knipe
et al., 1977; Schnitzer et al., 1979). This mutant could be
rescued by transcomplementation with wild-type G
(Whitt et al., 1989). In addition, it was shown that
transcomplementation with a G protein containing a tail
truncated from the normal 29 amino acids to 9 amino
acids also rescued infectivity of this virus. However, a G
protein with the tail truncated to a single amino acid was
unable to rescue the mutant virus (Whitt et al., 1989).
These results suggested the presence of a signal within
the cytoplasmic tail of G that is responsible for its incor-
poration into virions. Also, deletion of the cytoplasmic tail
of the rabies virus glycoprotein (G) led to decreased
incorporation of G into virions (Mebatsion et al., 1996).
This result suggests the tail of rabies G might interact
with an internal rabies virus protein to enhance budding.
Recent work with recombinant VSVs has demon-
strated that foreign glycoproteins expressed at high lev-
els are inserted efficiently into the envelope of VSV
(Kretzschmar et al., 1997; Schnell et al., 1996) without
requiring specific signals from VSV G. Indeed, replace-
ment of the cytoplasmic tail of the cellular CD4 protein
with that of VSV G did not increase its incorporation
levels in VSV particles (Schnell et al., 1996). This result
was consistent with an earlier study on incorporation of
CD4 and a CD4-G chimera into VSV particles (Schubert
et al., 1992). Other recent studies have confirmed that a
short cytoplasmic tail is required on VSV G to promote a
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high level of virus budding but that there is no specific
sequence requirement in that tail (Schnell et al., 1998). In
apparent conflict with the above studies, two studies
with HIV-1 Env-VSV G hybrids suggested a requirement
for the G tail to promote incorporation of Env into VSV
particles (Johnson et al., 1997; Owens and Rose, 1993).
In the work described here, we used VSV/HIV-1 Env
recombinants to reinvestigate the requirement for the
VSV G tail in incorporation of HIV envelope protein into
VSV particles. Specifically, we asked whether there might
be a negative signal in the HIV Env tail that prevented its
incorporation into VSV virions rather than a positive sig-
nal in the G tail that promoted incorporation of Env-G
hybrids. Our studies show that such a negative signal is
present within the membrane-proximal 10 amino acids of
the Env tail and that it functions by causing sequestration
of the Env protein at sites distinct from VSV budding
sites.
RESULTS
VSVs encoding HIV-1 Envs with cytoplasmic domain
mutations
Previous studies showed that HIV-1 Env protein was
not incorporated into VSV particles unless its cytoplas-
mic tail was replaced with that of VSV G (Johnson et al.,
1997; Owens and Rose, 1993). This result implied that
either the G tail contained a positive signal directing
incorporation into virions or that the HIV-1 Env tail con-
tained a negative signal preventing incorporation. To
analyze sequences affecting incorporation of HIV-1 Env
into VSV virions, we constructed a series of mutants
containing cytoplasmic tail truncations or substitutions.
Figure 1 summarizes the different constructs. VSVs en-
coding full-length Env, or gp160, and the chimeric
gp160G, which contains the gp160 extracellular and
transmembrane domains fused to the cytoplasmic do-
main of VSV G, have been described previously (Johnson
et al., 1997). We truncated the cytoplasmic tail of HIV-1
gp160 to 3, 10, or 29 amino acids (Envtr3, Envtr10, and
Envtr29, respectively) to determine whether the size of
the tail was critical for incorporation into virions and
whether a negative signal preventing incorporation was
present. Twenty-nine amino acids of the 150-amino-acid
gp160 tail were chosen as the longest tail because this
size corresponds to the length of the VSV G tail. Also,
previous complementation studies suggested that if a
negative signal existed, it would be within the membrane
proximal 29 amino acids (Owens and Rose, 1993). Fi-
nally, we tested a construct containing the CD4 cytoplas-
mic domain substituted for the gp160 cytoplasmic tail
because previous results indicated that the CD4 tail did
not prevent protein incorporation into VSV particles
(Schnell et al., 1996).
The constructs in Fig. 1 were prepared by PCR and
cloned into the pVSV-XN1 vector (Schnell et al., 1996).
These plasmids were used to generate infectious recom-
binant VSVs encoding the various Env constructs. Ex-
pression of each different Env protein at the cell surface
was verified by indirect immunofluorescence on infected
cells, and all appeared to be expressed at similar levels
(data not shown).
Infected cells expressing mutant Env proteins
We next verified the sizes of the proteins expressed by
labeling infected cells and analyzing the viral proteins
with the use of SDS–PAGE. Cells were infected with the
recombinant viruses for 4 h and labeled with [35S]methi-
onine for 1 h. Cell lysates were then analyzed directly
with SDS–PAGE. Results (Fig. 2) showed that the infected
cells expressed proteins of the proper sizes. HIV-1 Env is
synthesized as gp160, a full-length precursor molecule
that is cleaved into subunits gp120 (extracellular) and
gp41 (transmembrane) during transport to the cell sur-
face (Willey et al., 1988). Therefore, gp160 (160 kDa) is
the major band observed in infected cells, whereas the
gp120/gp41 subunits would be expected as the major
bands in virions (see Fig. 4). HIV-1 gp160 and gp160G
appeared as extra bands below VSV L (lanes 2 and 3).
Envtr29 migrated at the same position as gp160G (lanes
6 and 3), and the truncation mutants Envtr3 and Envtr10
appeared to be similar (lanes 4 and 5). As expected, the
gp160C, which contains the 38 amino acid tail of CD4,
migrated slightly slower than gp160G (lanes 7 and 3).
Cell surface expression of mutant Envs
Immunofluorescence microscopy suggested that the
proteins were expressed at similar levels on the cell
surface, but to obtain a quantitative measurement, we
FIG. 1. Cytoplasmic tail sequences of constructs. The C-terminal
sequences of the cytoplasmic tails of the indicated constructs are
shown. The gp160 tail sequence is 150 amino acids and is shown only
to position 29. The gp160G construct contains the first 3 amino acids of
the HIV-1 Env tail fused to the last 26 amino acids of the VSV G tail. The
gp160C construct contains the cytoplasmic tail of CD4 fused to the
transmembrane and extracellular domains of HIV-1 Env. Tm indicates
transmembrane domain; Cyt, cytoplasmic tail domain.
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analyzed release of the Env extracellular domain gp120.
Because the gp120–gp41 interaction is weak, gp120
present at the cell surface is released into the medium.
To measure this release, cells were infected with each
virus and labeled with [35S]methionine. The amount of
gp120 shed into the medium relative to the amount of G
in the medium was determined by immunoprecipitation
with a sheep anti-gp120 antibody and an anti-VSV G
antibody (Fig. 3). Lane 1 shows control precipitates from
cells infected with VSV revealing G as the major band.
The gp120 bands from the media of infected cells for
each virus are seen in Fig. 3, lanes 2–7. Quantification of
data from three experiments showed that the amount of
gp120 relative to G was similar for all constructs, sug-
gesting that the different proteins were expressed at very
similar levels on the cell surface. We also validated this
assay by performing immunoprecipitation of gp120 from
the cell surface (data not shown).
Incorporation into VSV particles
We next assayed for the extent of gp120 incorporation
into budded VSV particles. Viruses were purified and
their protein composition was analyzed by Western blot-
ting with anti-HIV-1 gp120 serum or anti-VSV serum. The
results are shown in Fig. 4. The blot with anti-VSV serum
(Fig. 4B) shows that roughly equal amounts of viral pro-
tein were loaded onto each lane, and this observation
was confirmed by quantification of VSV G. The blot with
anti-gp120 serum (Fig. 4A) shows the relative levels of
incorporation of gp120 in virions. The relative amounts of
gp120 were quantified with the highest level of incorpo-
ration (VSV-gp160G) set at a value of 100% (Fig. 4A, lane
3). A barely detectable level of incorporation (1%) was
seen for the VSV-gp160 virus (lane 2), whereas the Envtr3
mutant was incorporated at a level near that of the
gp160G (80%). The Envtr10 and Envtr29 gp120s were
FIG. 2. Expression of HIV-1 Env constructs. Cells were infected with
recombinant VSVs and radiolabeled after 4 h. Lysates were analyzed by
SDS–PAGE. Lane 1 indicates VSV; lane 2, VSV-gp160; lane 3, VSV-
gp160G; lane 4, VSV-Envtr3; lane 5, VSV-Envtr 10; lane 6, VSV-Envtr29;
and lane 7, VSV-gp160C. Positions of the five VSV proteins are marked
to the left. The sizes of the proteins are as follows: VSV L, 241 kDa; G,
63 kDa; N, 47 kDa; P, 30 kDa (migrates anomalously under N); M, 26
kDa; and HIV-1 gp160, 160 kDa
FIG. 3. Release of gp120 from infected cells. Cells were infected for
3 h, radiolabeled for 2 h, and then incubated in chase medium con-
taining unlabeled methionine for 3 h. Immunoprecipitation from the
medium was performed using a mixture of anti-gp120 and anti-VSV G
antibodies. After SDS–PAGE analysis, protein levels were determined
using a PhosphorImager. Lane 1 indicates VSV; lane 2, VSV-gp160; lane
3, VSV-gp160G; lane 4, VSV-Envtr3; lane 5, VSV-Envtr10; lane 6, VSV-
Envtr29; and lane 7, VSV-gp160C. The positions of VSV G and HIV-1
gp120 are marked to the right.
FIG. 4. Western blots of purified viruses. Cells were infected over-
night, and virus was purified from the medium by centrifugation twice
through a 10% sucrose solution. Equal amounts of protein from each
virus were used for each blot. (A) Blot probed with polyclonal sheep
anti-HIV gp120. (B) Blot probed with polyclonal rabbit anti-VSV. For each
blot, lane 1 indicates VSV; lane 2, VSV-gp160; lane 3, VSV-gp160G; lane
4, VSV-Envtr3; lane 5, VSV-Envtr10; lane 6, VSV-Envtr29; and lane 7,
VSV-gp160C. See Fig. 2 for protein sizes.
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incorporated at levels of 5% and 6%, respectively. These
results are consistent with the presence of a sequence
in the membrane proximal 10 residues of gp160 that
interferes with incorporation.
Interestingly, the VSV-gp160C, which contains the CD4
cytoplasmic tail, was also poorly incorporated (3%) into
virions (Fig. 4A, lane 7). This result was unexpected
because CD4 is incorporated efficiently into VSV virions,
as is a chimeric G protein in which the cytoplasmic tail
has been replaced with that of CD4 (Schnell et al., 1998,
1996). Thus placement of an apparently neutral se-
quence in a new context can generate a negative signal
for incorporation.
Surface distribution of HIV-1 Env constructs in
infected cells
To compare the distribution of gp160 and gp160G with
VSV G in the plasma membrane, laser scanning micros-
copy was performed on cells infected with either VSV-
gp160 or VSV-gp160G (Fig. 5). Infected cells were fixed
and stained with anti-G and anti-gp120 antibodies fol-
lowed by detection with rhodamine-conjugated (G) and
fluorescein-conjugated (gp120) secondary antibodies.
Figure 5A shows images obtained from an optical
section of cells infected with VSV-gp160 (panels 1–3) or
VSV-gp160G (panels 4–6). The gp160 and G had different
distributions within the same cells, whereas gp160G and
G colocalized throughout the plasma membrane. For
example, in the optical sections of cells infected with
VSV-gp160, G was concentrated in a punctate pattern
and in membrane blebs protruding from the cell surface
(panel 2, arrows), whereas gp160 appeared in a diffuse
pattern over the cell surface and was excluded from the
blebs (panel 1, arrows). In other areas, gp160 was con-
centrated in regions where G was reduced (arrowheads).
The distinct distributions of gp160 and G are clear in
panel 3, which shows the merge of panels 1 and 2. The
regions of G enrichment (red, arrows) were distinct from
areas of gp160 enrichment (green, arrowheads). Areas of
overlap appear yellow. In VSV-gp160G-infected cells, the
gp160G expression pattern coincided with that of G in all
areas of the plasma membrane, including the membrane
blebs (Fig. 5A, panels 3 and 4), and the merge shows
complete overlap (panel 6, yellow).
To compare the distribution of the proteins over the
entire cell surface, the cells were optically sectioned
from top to bottom, and projection images were gener-
ated from the resulting stack of sections. Figure 5B
shows the projection images of cells infected with VSV-
gp160 (panels 7–9) or with VSV-gp160G (panels 10–12).
These images show that membrane blebs containing G
were distributed over the entire cell surface (panels 8
and 11). Although gp160 was excluded from these blebs
(panel 9, arrows), gp160G colocalized with G in the blebs
and other regions of the plasma membrane (panels 10–
12). The extent of gp160 or gp160G colocalization with G
at the cell surface therefore correlated with the abilities
of these proteins to be efficiently incorporated into viri-
ons (see Fig. 4).
Figure 6 shows the expression patterns of the HIV-1
Env mutants and VSV G at the surface of infected cells.
Each image is a projection generated as described for
Fig. 5B. Overall, the extent of colocalization of each Env
protein with VSV G coincided with the incorporation data
in Fig. 4. For example, the Envtr3 protein (like gp160G)
colocalized with G (Fig. 6, panels 1 and 2) in distinct
regions across the entire cell surface. However, the
Envtr29 protein (panels 5 and 6) showed a much more
diffuse distribution than G that was similar to gp160 and
did not correspond to the punctate distribution of VSV G.
Arrows denote areas of G enrichment where Envtr29 was
absent. There also were some areas in which the En-
vtr29 and G expressions overlapped, which was consis-
tent with a low level of incorporation into virions seen in
Fig. 4A. Similar results were observed for the Envtr10
mutant (panels 3 and 4), which, for the most part, did not
colocalize with G. There were some areas of overlap,
which again was consistent with the low-level incorpo-
ration into virions seen in Fig. 4A. Finally, the gp160C
expression pattern (panel 7) did not correspond with G
(panel 8), which is consistent with the poor incorporation
of the gp160C protein into virions.
DISCUSSION
Recent results from our laboratory have shown that no
specific VSV G cytoplasmic tail sequences are required
for high-level incorporation of many foreign glycoproteins
into VSV (Kretzschmar et al., 1997; Schnell et al., 1996,
1997) or even for incorporation of G protein itself (Schnell
et al., 1998). The HIV-1 Env protein thus is the only protein
we studied that appeared to require the G cytoplasmic
tail for efficient incorporation into VSV virions (Johnson et
al., 1997; Owens and Rose, 1993). The work described
here revealed that rather than providing a positive signal
for incorporation of HIV-1 Env, the substitution of the G
tail for the HIV-1 Env tail eliminated a negative signal
present within the HIV-1 Env tail. The large size of the
full-length Env tail (150 amino acids) was not responsible
alone for its poor incorporation into VSV particles. In-
deed, when the tail was truncated to 29 amino acids (the
same size as the G tail) or even 10 amino acids, the
incorporation into VSV virions remained poor. However,
when the tail was shortened to 3 amino acids, the incor-
poration increased to levels nearly equal to those ob-
tained with the G tail substitution. Thus we conclude that
the HIV-1 Env tail contains a negative signal within the
membrane proximal 3–10 amino acids that prevents in-
corporation into VSV virions.
Confocal immunofluorescence microscopy showed
that VSV G protein was present in a punctate pattern or
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FIG. 5. Confocal microscopy of cells infected with VSV-gp160 and VSV-gp160G. Infected cells were labeled with antibodies to gp120 and VSV G
after 12 h. (A) An optical section of cells infected with VSV-gp160 (panels 1–3) or VSV-gp160G (panels 4–6). Panels 1 and 4 show anti-HIV-1 gp160
(FITC-conjugated secondary antibody); panels 2 and 5, anti-VSV G (rhodamine-conjugated secondary antibody); panel 3, merge of panels 1 and 2; and
panel 6, merge of the panels 4 and 5. (B) Projection images constructed from optical sections through cells. Panels 7–9 show VSV-gp160 infected;
panels 10–12, VSV-gp160G infected. Panels 7 and 10 show anti-HIV-1 gp120 (FITC-conjugated secondary antibody); panels 8 and 11, anti-VSV G
(rhodamine-conjugated secondary antibody); panel 9, merge of panels 7 and 8; and panel 12, merge of panels 10 and 11. Arrows indicate areas of
concentrated VSV G that lack HIV-1 Env, and arrowheads indicate the reverse. Areas where red and green overlap (indicating protein colocalization)
appear yellow in merged panels. The white bars represent 5 mm.
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in large membrane blebs at the cell surface, whereas the
HIV-1 Env constructs that were mostly excluded from
virions were also excluded from regions of the plasma
membrane enriched for G. These regions of G protein
concentration probably correspond to sites of VSV bud-
ding because additional experiments showed that the
regions of VSV G protein concentration also corre-
sponded to sites of VSV M concentration (Price, W. Rod-
gers, J. E. Johnson, and J. K. Rose, unpublished observa-
tions). We have also used confocal microscopy to local-
ize gp160 and G, or gp160G and G proteins expressed
without other VSV proteins. We found results similar to
what we saw in VSV-gp160- and VSV-gp160G-infected
cells, although the differences in gp160 and G distribu-
tions were less dramatic. These results argue that the
different distributions are at least partly independent of
FIG. 6. Projection images of cells expressing HIV-1 Env mutants. Surfaces of infected cells were fixed and stained with antibodies to HIV-1 gp120
and VSV G after 12 h of infection. Panels 1 and 2 show VSV-Envtr3; panels 3 and 4, VSV-Envtr10; panels 5 and 6, VSV-Envtr29; panels 7 and 8,
VSV-gp160C. Panels 1, 3, 5, and 7 show anti-HIV-1 gp160 (FITC-conjugated secondary antibody); panels 2, 4, 6, and 8, anti-VSV G (rhodamine-
conjugated secondary antibody). Arrows indicate areas of concentrated VSV G lacking HIV-1 Env, and arrowheads indicate the reverse. White bars
represent 5 mm.
249PLASMA MEMBRANE LOCALIZATION SIGNAL IN HIV ENV
other VSV proteins and the budding process. Budding
may enhance the differences by further concentrating
proteins in virions.
Understanding the nature of signals that generate a
pattern of Env protein localization distinct from VSV G is
complicated because an additional HIV-1 Env construct
with the CD4 cytoplasmic domain replacing that of the
HIV-1 Env showed a distribution different from that of G
and was not incorporated into virions. This result was
unexpected because previous work in our laboratory
showed that CD4 itself and even a G protein bearing the
cytoplasmic tail of CD4 were incorporated efficiently into
VSV particles (Schnell et al., 1996, 1998). It is likely that
the folding of the CD4 tail or adjacent regions is altered
in the gp160C construct, which may have generated a
novel signal that prevented localization at VSV budding
sites. It is also quite possible that the negative signal in
the Env tail functions through effects on folding rather
than through direct interactions with other proteins in-
volving the specific amino acid sequence of the mem-
brane proximal amino acids.
It has been shown that the HIV-1 Env protein is endo-
cytosed in cells not expressing the HIV-1 Gag proteins
(Egan et al., 1996; Rowell et al., 1995) and that a tyrosine
residue within the first 10 amino acids of the cytoplasmic
tail is part of an endocytosis signal for Env (Egan et al.,
1996). Although we observed similar amounts of HIV-1
Env and Env tail mutants on the cell surface, it is possible
that the endocytosis signal caused localization at sites
distinct from sites of VSV budding and thus prevented
incorporation. However, this model seems unlikely be-
cause there also is an endocytosis signal in the VSV G
tail (Roth et al., 1986), and this signal would have to
function to cause localization at sites distinct from sites
recognized by the Env signal. Also, there is an endocy-
tosis signal in the cytoplasmic domain of CD4 (Shin et al.,
1990, 1991), yet CD4 is incorporated efficiently into VSV
virions.
An understanding of the factors influencing protein
localization and incorporation into VSV virions will re-
quire more detailed analysis of the membrane domains
in which the proteins are localized. Additional mutants
containing amino acid substitutions or small deletions
may identify single residues or domains within the Env
cytoplasmic region responsible for the negative signal.
Presumably, this negative signal functions as a positive
signal in HIV-1-infected cells to enhance localization of
HIV-1 Env at sites of HIV-1 budding. Interactions with
other cellular proteins are likely to be involved in deter-
mining the distribution of HIV-1 Env, and they may be
identified by additional experiments such as coimmuno-
precipitation or genetic screens for protein–protein inter-
action. In addition, it is possible that protein–lipid inter-
actions are affecting protein distribution and localization
to specific membrane domains.
MATERIALS AND METHODS
Plasmids and constructs
Constructs were prepared using standard recombi-
nant DNA and PCR strategies. The plasmid pNL4–3
(Adachi et al., 1986) was used as a template for all
reactions. Full-length Env and the Env-G constructs were
previously described (Johnson et al., 1997) and are here-
after referred to as gp160 and gp160G. Truncation mu-
tants were prepared using the forward primer containing
the underlined XhoI site in each case: 59-GGACGC-
GTCTCGAGATTATGAGAGTGAAGGAG-39. Reverse prim-
ers containing stop codons in the appropriate positions
were used to introduce the truncations in the cytoplas-
mic tail of the protein. Primers used contained the fol-
lowing sequences: for Envtr3 (3-amino-acid tail), 59-TTA-
AGGCCTCTAGACTACCTAACTCCTATTCACTATAGA-39;
Envtr10 (10-amino-acid tail), 59-TTAAGGCCTCTAGACTA-
CGATAATGGTGAATATCCCCTG-39; and Envtr29 (29-
amino-acid tail), 59-TTAAGGCCTCTAGACTATTCTTCTAT-
TCCTTCGGGCCT-39. Reverse complements of stop
codons appear in bold, and downstream XbaI sites are
underlined. PCR products were cloned into the vector
pVSV-XN1 (Schnell et al., 1996), which was cut with XhoI
and NheI, and the resulting plasmids were named pVSV-
Envtr3, pVSV-Envtr10, and pVSV-Envtr29.
The construct containing the Env extracellular and
transmembrane domains fused to the CD4 cytoplasmic
tail was also prepared using PCR. The CD4 tail was
amplified using a forward primer that contained Env
coding sequence fused to CD4 tail coding sequences
(underlined), as follows: 59-GCTGTACTTTCTATAGTGAAT-
AGGTGCCGCCACCGAAGGCGC-39. The reverse primer
contained a downstream XbaI site (underlined), as fol-
lows: 59-AATTCCGGTCTAGAGCCTCAAATGGGGCTACA-
TGT-39. After PCR with these two primers and pBS-CD4
template in a total volume of 50 ml, a second PCR was
performed using the pNL4–3 template, 1 ml of the prod-
uct from the first PCR, and the forward primer listed
above for Env and the reverse primer encoding the CD4
stop codon and the XbaI site described. This second
PCR product was cloned into pVSV-XN1, which was cut
with XhoI and NheI, and the resulting plasmid was des-
ignated pVSV-gp160C.
Virus recoveries
Recombinant viruses were recovered as previously de-
scribed (Schnell et al., 1996). BHK cells were infected with
vTF7–3, a recombinant vaccinia virus expressing T7 poly-
merase, and subsequently transfected with a mixture of
plasmids containing 10 mg of pVSV-Envtr3, 10, or 29 or
pVSV-gp160C; 3 mg of pBS-N; 5 mg of pBS-P; and 2 mg of
pBS-L. After 2 days, the supernatants were filtered to re-
move vaccinia virus and passed onto fresh BHK cells. After
2 additional days, supernatants were passed onto fresh
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BHKs on coverslips, and recoveries were assayed by indi-
rect immunofluorescence staining for VSV G.
Metabolic labeling
BHKs (2 3 105/35-mm plate) were infected with each
virus at a multiplicity of infection (m.o.i.) of 1 in 0.5 ml of
DMEM for 30 min at 37°C. Then, 2 ml of DMEM supple-
mented with 5% FBS was added to each dish. After a
total of 4 h at 37°C, medium was replaced with 1 ml of
methionine-free DMEM containing 100 mCi of [35S]me-
thionine and incubated for 1 h at 37°C. Cells were
washed in PBS and lysed in detergent solution (1% Non-
idet P-40, 0.4% deoxycholate, 50 mM Tris–HCl, pH 8, 62.5
mM EDTA). Lysates then were separated by 10% SDS–
PAGE (Laemmli, 1970). The gel was dried and exposed to
a PhosphorImager screen (Molecular Dynamics).
Microscopy
BHK cells (2 3 105/plate on sterile coverslips or 35-
mm, glass-bottom microwell plates; MatTek) were in-
fected with viruses at an m.o.i. of 1 for overnight infec-
tions or 10 for 12-h infections. The cells were then fixed
in 3% paraformaldehyde at room temperature for 20 min,
rinsed twice in PBS containing 10 mM glycine (PBS–
glycine), and labeled with sheep polyclonal anti-gp120 at
1:100 and mouse anti-VSV G at 1:200. After 20–30 min at
37°C, the antibodies were washed off, and the cells were
rinsed twice in PBS–glycine. Cells were then incubated
with lissamine rhodamine-conjugated anti-mouse and
FITC-conjugated anti-sheep antibodies at 1:50 for 20–30
min at 37°C. After two final rinses in PBS–glycine, cov-
erslips were mounted onto slides and observed using a
Nikon Microphot-FX microscope equipped with a 403
planapochromat objective. Cells on microwell plates
were observed using a BioRad MRC 600 laser scanning
confocal imaging system interfaced with a Zeiss inverted
microscope. The light source was a krypton–argon laser.
Fluorescein and rhodamine were excited at 488 and 569
nm, respectively. Emission wavelengths between 487
and 557 nm were collected for fluorescein imaging, and
emission wavelengths of .585 nm were collected for
rhodamine imaging. Fluorescein and rhodamine were
collected simultaneously in separate channels. Images
were acquired by averaging for two frames using a
Kalman function (BioRad). To visualize the distributions of
proteins over the cell surface, projections were gener-
ated from optically sectioned cells using IP Lab Spec-
trum software (Signal Analytics Corp.). A step size of
0.3–0.5 mm was used for the optical sectioning.
Radiolabeling and immunoprecipitation
Radiolabelings and immunoprecipitations were per-
formed as described with the following changes (John-
son et al., 1997). Cells (5 3 105/plate) were infected with
each virus at an m.o.i. of 10 in 1 ml of DMEM/5% FBS at
37°C for 3 h. Each plate of cells was labeled with 150 mCi
of [35S]methionine in 1 ml of methionine-free DMEM for
2 h at 37°C. The medium was then removed and re-
placed with DMEM containing 2% FBS and 2 mM methi-
onine and incubated for 3 h at 37°C. Cells were rinsed in
PBS and lysed in 0.5 ml of detergent solution (1% Nonidet
P-40, 0.4% deoxycholate, 50 mM Tris–HCl, pH 8, 62.5 mM
EDTA) containing 5 U of aprotinin. Detergent solution
was added to culture media before immunoprecipitation.
For immunoprecipitations, lysates and medium were
incubated with 30 ml of Pansorbin (Calbiochem) for 30
min at 37°C to reduce immunoprecipitation of nonspe-
cific proteins. The samples were centrifuged for 2 min at
14,000 rpm, and the supernatants were transferred to
new tubes. The immunoprecipitations were then per-
formed as described previously (Johnson et al., 1997)
using 2 ml of sheep anti-gp120, 2 ml of mouse anti-G, and
45 ml of Pansorbin per sample. Samples were analyzed
by SDS–PAGE as described above.
Western blots
BHK cells (106/10-cm dish) were infected with each
virus at an m.o.i. of 5 in 5 ml of DMEM/5% FBS for ;16 h
at 37°C. Virus was purified by ultracentrifugation twice
through a 10% sucrose solution as previously described
(Johnson et al., 1997).
The absorbance of each sample at 260 nm was mea-
sured along with a BSA standard of known concentration,
and these measurements were used to determine the pro-
tein concentration in each virus sample. Equal amounts of
protein from each sample were separated by 10% SDS–
PAGE. Gels were transferred to nitrocellulose at 200 mA for
2.5 h. Blots were blocked overnight at 4°C in TTBS blocking
buffer (100 mM Tris–HCl, pH 7.5, 0.5 mM NaCl, and 1%
Tween 20, containing 1% BSA). Blots were probed with
sheep anti-gp120 or rabbit anti-VSV, both at 1:5000 dilutions,
for 1 h at room temperature in blocking buffer. Blots were
washed three times for 5 min each in TTBS. Secondary
antibodies (Vector laboratories) were biotinylated rabbit an-
ti-sheep and biotinylated goat anti-rabbit and were used at
1:10,000 in blocking buffer for 1 h at room temperature. After
additional TTBS washes, blots were incubated in peroxi-
dase-conjugated strepavidin (Amersham) at 1:10,000 in
blocking buffer for 1 h at room temperature. Blots were
washed again and detected using enhanced chemilumi-
nescence (ECL) reagents (Amersham), followed by expo-
sure to film. Films were scanned (Molecular Dynamics) and
quantified using ImageQuant software.
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